Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Psyence Biomedical Ltd. - Common Shares (NQ:PBM)

7.600 +1.730 (+29.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,506,163
Open 9.820
Bid (Size) 8.330 (100)
Ask (Size) 8.490 (100)
Prev. Close 5.870
Today's Range 7.110 - 10.53
52wk Range 0.3743 - 12.64
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's after hours session ↗
Via Chartmill
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill

Performance

YTD
+851.2%
+851.2%
1 Month
+223.4%
+223.4%
3 Month
+772.8%
+772.8%
6 Month
+122.2%
+122.2%
1 Year
+1778.4%
+1778.4%

More News

Read More
These stocks have an unusual volume in today's session ↗
Via Chartmill
Friday's session: top gainers and losers ↗
Via Chartmill
Why Is PBM Stock Drawing So Much Investor Interest Today? ↗
Via Stocktwits
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science ↗
Via Stocktwits
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program ↗
Via Stocktwits
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets ↗
Via Stocktwits
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs ↗
Via Stocktwits
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care ↗
Via Stocktwits
What's going on in today's session ↗
Via Chartmill
Which stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Thursday's session. ↗
Via Chartmill
News headline image
Top movers in Thursday's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Psyence Biomedical Ltd. - Common Shares publicly traded?
Yes, Psyence Biomedical Ltd. - Common Shares is publicly traded.
What exchange does Psyence Biomedical Ltd. - Common Shares trade on?
Psyence Biomedical Ltd. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Psyence Biomedical Ltd. - Common Shares?
The ticker symbol for Psyence Biomedical Ltd. - Common Shares is PBM on the Nasdaq Stock Market
What is the current price of Psyence Biomedical Ltd. - Common Shares?
The current price of Psyence Biomedical Ltd. - Common Shares is 7.600
When was Psyence Biomedical Ltd. - Common Shares last traded?
The last trade of Psyence Biomedical Ltd. - Common Shares was at 04/17/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.